脐血CHD13 DNA甲基化与10至14岁时脂联素水平相关
研究纳入高血糖与不良妊娠结局研究及其随访研究的2265名儿童,平均年龄11.4±1.2岁,评估脂联素作为青少年不良代谢健康生物标志物,并分析脐血DNA甲基化与儿童脂联素水平的关联。结果显示较低脂联素与较高肥胖及糖代谢异常指标相关,脐血CDH13位点cg02713721甲基化与儿童脂联素水平相关(β=0.35,Bonferroni校正P=0.01)。
要点
- 儿童期较低脂联素水平与更高肥胖及糖代谢异常指标相关。
- 脐血CDH13位点cg02713721甲基化与儿童脂联素水平相关。
- 脂联素可能是青少年不良代谢健康的生物标志物。
核心结论
- 本研究提供证据表明脂联素是青少年不良代谢健康的生物标志物。
- CDH13基因(参与血糖调节)的甲基化与儿童脂联素水平相关,提示其可能参与未来代谢健康的编程。
研究设计与样本
- 研究纳入高血糖与不良妊娠结局研究及其随访研究的参与者,基于脐血DNA甲基化、儿童人体测量学、儿童脂联素水平和口服葡萄糖耐量试验指标的可及性(n=2265),数据收集时平均年龄11.4±1.2岁。
- 采用偏相关评估儿童对数转换脂联素与儿童肥胖及血糖指标之间的横断面关联。
- 采用线性回归模型对脐血DNA甲基化与儿童脂联素水平进行全表观基因组关联分析,并校正协变量。
主要发现
- 校正协变量后,儿童较低脂联素水平与较高肥胖/糖代谢异常结局相关:皮褶厚度总和r=-0.285,血糖z评分总和r=-0.070。
- 校正协变量后,儿童较低脂联素水平与较低Matsuda指数(r=0.135)和处置指数(r=0.062)相关。
- 位于CDH13位点的cg02713721脐血DNA甲基化与儿童脂联素水平相关(β=0.35,Bonferroni校正P=0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Low adiponectin levels are associated with higher insulin resistance, the development of type 2 diabetes, and greater adiposity in adults, but the evidence in youth is limited. This study aimed to assess adiponectin as a biomarker of adverse metabolic health in youth and to examine whether cord blood DNA methylation (cbDNAm) is associated with child adiponectin levels. METHODS: Participants from the Hyperglycemia and Adverse Pregnancy Outcome Study and Follow-up Study were included based on availability of cbDNAm, child anthropometry, child adiponectin levels, and glucose oral glucose tolerance test measures (n = 2265) collected at mean age 11.4 ± 1.2 years. Cross-sectional associations between child log-transformed adiponectin and child adiposity and glycemic measures were evaluated via partial correlation. Linear regression models were used for epigenome-wide analysis of cbDNAm and child adiponectin levels. RESULTS: After adjustment for covariates, lower child adiponectin levels were correlated with higher adiposity/dysglycemia outcomes (sum of skinfolds, r = -0.285 and glucose sum of z-scores, r = -0.070) as well as lower Matsuda (r = 0.135) and disposition (r = 0.062) indices. Linear regression was used to assess associations between cbDNAm and child adiponectin levels with covariate adjustments. cbDNAm at cg02713721, located in the CDH13 locus, was associated with child adiponectin levels (β = .35, Bonferroni-adjusted P = .01). CONCLUSION: This study provides evidence of adiponectin as a biomarker of adverse metabolic health in youth. The association of methylation in CDH13, a gene involved in glucose regulation, with child adiponectin levels suggests a contribution to programming of future metabolic health.
引用
- Bianco ME, Gurra MG, Scholtens DM, et al. Cord Blood DNA Methylation at CHD13 Is Associated with Adiponectin Levels at 10 to 14 Years of Age. J Clin Endocrinol Metab. 2026. PMID: 40587656. doi:10.1210/clinem/dgaf369
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。